Fluticasone furoate/Vilanterol Inhalation Powder

DRUG4 trials

Sponsors

GlaxoSmithKline

Conditions

Asthma

Phase 3

Study HZA106829: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics

CompletedNCT01134042

GlaxoSmithKlineAsthma

Start: 2010-06-30End: 2011-10-31Updated: 2017-01-11

HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents

CompletedNCT01147848

GlaxoSmithKlineAsthma

Start: 2010-06-30End: 2011-07-31Updated: 2017-01-18

Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics

CompletedNCT01165138

GlaxoSmithKlineAsthma

Start: 2010-08-20End: 2011-10-19Updated: 2018-02-14

A Study of a New Asthma Medicine in Asthmatics Whose Asthma Worsens With Exercise

WithdrawnNCT01435902

GlaxoSmithKlineAsthma

Start: 2012-01-31End: 2012-08-31Updated: 2014-06-23

Related Papers

Integrated safety and efficacy analysis of once-daily fluticasone furoate for the treatment of asthma

Respiratory Research2016-11-2311 citations

An Integrated Analysis of Fluticasone Furoate/Vilanterol (FF/VI) Versus FF Safety Data Across Phase II and III Asthma Studies

Pulmonary Therapy2016-05-121 citations

Ethnic sensitivity assessment of fluticasone furoate/vilanterol in East Asian asthma patients from randomized double-blind multicentre Phase IIb/III trials.

2015-12-246 citations